Company: TAK
Filing Date: 2025-06-25
Form Type: 20-F
Source: 0001395064-25-000095
Chunk: 254

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-06-25
Form: 20-F
Item: Item 19
Chunk 254
---
 for sale as a result of a transfer agreement Takeda entered into. The transfer was completed in May 2025.

• Following an agreement Takeda entered into to transfer business operations related to MEPACT, Takeda classified the assets, including goodwill allocated to the business, as held for sale. The transfer was completed in May 2025.

• Takeda entered into an agreement to transfer business operations related to non-core products in the Middle East and North Africa regions and classified the corresponding goodwill as held for sale. The transfer was completed in June 2025.

During the fiscal year ended March 31, 2025, Takeda recognized a divestiture gain in other operating income (Note 5) upon the completion of transfer of the manufacturing operation of TACHOSIL and the proceeds from this divestiture are reflected in Takeda’s proceeds from sales of business (net of cash and cash equivalents divested) in the consolidated statements of cash flows of JPY 20,556

When disposal groups were classified as held for sale, Takeda recorded an impairment loss of JPY 4,693 1,685 6,812

F-45

20. Bonds and Loans

                        JPY (millions)                                
                        As of March 31                                
                        2024                                          
 ──────────────────────────────────────────────────────────────────────
  Bonds                 ¥                   4,092,879      4,190,632  
  Short-term loans      251                                   74,621  
  Long-term loans                             750,622        250,012  
  Total                 ¥                   4,843,752      4,515,265  
  Non-current           ¥                   4,476,501      3,966,326  
  Current               ¥                     367,251        548,939  

The composition of bonds is as follows:

  Instrument                                                                                                                     JPY (millions)                                                                                                                                                      Maturity                       
                                                                                                                                 Carrying amount                                                                                                                                                                                    
                                                           Principal amount in contractual currency (millions)                   As of                                              Interest rate (%)                                                                                                                               
                                                                                                                                 March 31, 2024                                                                                                                                                                                     
  2019 Hybrid bonds (subordinated bonds)                   ¥                                                        500,000                             499,614                     1.720% per annum through October 6, 2024 and 6 month LIBOR + margin ( 1.750 - 2.750%) thereafter                 June 2079 (7